Sascan Meditech
Early screening for most squamous cell cancers is not possible because of low diagnostic accuracy, high costs and painful procedures. Our misison is to make screening technology so accurate, painless and cheap that screening can be had as routinely as dental checkups
46.1
46.1
NaN
NaN
NaN
NaN
Valuation
$
Valuation
Funding
$
Funding
Statistics
NA
Ventures > Sascan Meditech
Sascan Meditech
Active
Action
Early screening for most squamous cell cancers is not possible because of low diagnostic accuracy, high costs and painful procedures. Our misison is to make screening technology so accurate, painless and cheap that screening can be had as routinely as dental checkups
- Funding
0and0